Sangamo Therapeutics
SGMO
SGMO
128 hedge funds and large institutions have $62.9M invested in Sangamo Therapeutics in 2024 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 33 increasing their positions, 29 reducing their positions, and 16 closing their positions.
Holders
128
Holders Change
+25
Holders Change %
+24.27%
% of All Funds
1.7%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
42
Increased
33
Reduced
29
Closed
16
Calls
$1.87M
Puts
$3.36M
Net Calls
-$1.49M
Net Calls Change
-$466K
Top Buyers
1 |
1
State Street
Boston,
Massachusetts
|
$5.12M |
2 |
2
Point72 Asset Management
Stamford,
Connecticut
|
$2.32M |
3 |
IC
3
Ikarian Capital
Dallas,
Texas
|
$1.9M |
4 |
SSA
4
Schonfeld Strategic Advisors
New York
|
$1.74M |
5 |
5
BlackRock
New York
|
$5.3M |